WGS
Price:
$104.95
Market Cap:
$3.13B
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Industry
Medical - Diagnostics & Research
IPO Date
2020-11-04
Stock Exchange
NASDAQ
Ticker
WGS
According to GeneDx Holdings Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 291.53. This represents a change of -716.67% compared to the average of -47.27 of the last 4 quarters.
The mean historical PE Ratio of GeneDx Holdings Corp. over the last ten years is -43.88. The current 291.53 PE Ratio has changed -66531.06% with respect to the historical average. Over the past ten years (40 quarters), WGS's PE Ratio was at its highest in in the December 2024 quarter at 96.07. The PE Ratio was at its lowest in in the September 2025 quarter at -99.76.
Average
-43.88
Median
-10.99
Minimum
-178.16
Maximum
-0.16
Discovering the peaks and valleys of GeneDx Holdings Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.32%
Maximum Annual PE Ratio = -0.16
Minimum Annual Increase = -91.73%
Minimum Annual PE Ratio = -178.16
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -178.16 | 349.70% |
| 2024 | -39.62 | 10.32% |
| 2023 | -0.38 | 134.20% |
| 2022 | -0.16 | -91.73% |
| 2021 | -1.96 | -82.12% |
| 2020 | -10.99 | -85.53% |
The current PE Ratio of GeneDx Holdings Corp. (WGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-72.72
5-year avg
-44.06
10-year avg
-43.88
GeneDx Holdings Corp.’s PE Ratio is greater than Hinge Health, Inc. (70.34), greater than Kymera Therapeutics, Inc. (-36.46), greater than TransMedics Group, Inc. (19.61), greater than Viking Therapeutics, Inc. (-6.30), greater than Oscar Health, Inc. (18.70), greater than Immunovant, Inc. (-13.35), greater than Privia Health Group, Inc. (89.33), greater than Crinetics Pharmaceuticals, Inc. (-16.82), greater than Option Care Health, Inc. (18.42), greater than NewAmsterdam Pharma Company N.V. (-10.06),
| Company | PE Ratio | Market cap |
|---|---|---|
| 70.34 | $7.33B | |
| -36.46 | $9.75B | |
| 19.61 | $3.00B | |
| -6.30 | $3.42B | |
| 18.70 | $8.29B | |
| -13.35 | $7.77B | |
| 89.33 | $2.53B | |
| -16.82 | $9.00B | |
| 18.42 | $3.67B | |
| -10.06 | $2.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneDx Holdings Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GeneDx Holdings Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is GeneDx Holdings Corp.'s PE Ratio?
How is the PE Ratio calculated for GeneDx Holdings Corp. (WGS)?
What is the highest PE Ratio for GeneDx Holdings Corp. (WGS)?
What is the 3-year average PE Ratio for GeneDx Holdings Corp. (WGS)?
What is the 5-year average PE Ratio for GeneDx Holdings Corp. (WGS)?
How does the current PE Ratio for GeneDx Holdings Corp. (WGS) compare to its historical average?